Aktuelles

Bilder

New video series
New seed monopolies through NGT
previous pauseresume next

Genetically engineered oilseed rape out of control

Plants can no longer be withdrawn from the environment
Tuesday, 17 September 2013
Munich/Calgary
Today Testbiotech has published a global overview of countries where there has been an uncontrolled spread of genetically engineered oilseed rape (canola). The countries include Canada, the US, Japan, Australia and Europe. In many cases the plants have escaped far beyond the fields into the environment. In some cases, the transgenes have moved into populations of wild relatives. Furthermore, new combinations of DNA constructs have been found which were never approved for release into the environment. The overview has been published to coincide with the international conference (ABIC) in Calgary, where agro-biotech industry representatives are gathering.

European Union set to decide on the import of Monsanto drought resistant maize

Munich/ Parma 12.9.2012 In a meeting taking place in Brussels tomorrow, the EU Commission and experts from EU Member States will discuss and probably vote on the import of a genetically maize produced by Monsanto (MON87460) that is supposedly drought tolerant.

Monsanto starts to withdraw EU applications for cultivation of genetically engineered plants

Decision concerns at least four applications for insecticidal and herbicide tolerant maize
Monday, 26 August 2013
Parma/Munich

Monsanto has now withdrawn at least four applications after it announced that it would no longer push for the cultivation of new genetically engineered plants in the EU. The decisions concern genetically engineered maize (Mon89034, NK603 x MON810, MON89034 x Nk603, Mon89034x Mon88017) which produce insecticidal proteins and/ or is made resistant to herbicide glyphosate („Roundup“). This information is derived from the register of European Food Safety Authority EFSA. There are more applications pending from Monsanto for transgenic plants such as maize, soy, sugar beet which still seem to be valid.

European Patent on chimpanzees manipulated to develop cancer

Bionomics granted patent on human genes and genetically engineered great apes
Thursday, 8 August 2013
Munich

The European Patent Office (EPO) has again granted a patent that covers genetically engineered chimpanzees and other non-human primates. EP1364025 was granted on 31 July 2013 to Bionomics (Australia). The company claims human genes presumed to play a role in the prevention of cancer as an invention. According to the patent, the genes will be used to genetically manipulate the chimpanzees. As a result of the genetic manipulation, the great apes can have a higher risk of developing cancer.

Pages

Alle | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009